Tom Culman is an engagement associate at RA Capital, where he manages a variety of educational, outreach, and advocacy-oriented projects including the "Business of Biotech" short course.
Increasing out-of-pocket costs by just $10 per prescription causes a 33% rise in mortality because fewer patients take the drugs their doctors prescribe.